Showing results (481-490 of 517) with videos related to

Sort By:
Pageof 52
Vaccines|April 30, 2021
Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like ParticlesLisha Zha, Xinyue Chang, Hongxin Zhao, et al.
Vaccines|September 28, 2017
Microcrystalline Tyrosine (MCT®): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in MalariaGustavo Cabral-Miranda, Matthew D Heath, Ariane C Gomes, et al.
Anticancer Research|June 10, 2010
Overexpression of p150, a part of the large subunit of the eukaryotic translation initiation factor 3, in colon cancerJ Haybaeck, T O'Connor, R Spilka, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2015
Development of an Interleukin-1β Vaccine in Patients with Type 2 DiabetesClaudia Cavelti-Weder, Katharina Timper, Eleonora Seelig, et al.
European Journal of Immunology|July 19, 2012
Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8⁺ T-cell responses in melanoma patientsSimone M Goldinger, Reinhard Dummer, Petra Baumgaertner, et al.
Allergy|October 10, 2023
Influence of antigen density and TLR ligands on preclinical efficacy of a VLP-based vaccine against peanut allergyPascal S Krenger, Romano Josi, Jan Sobczak, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 24, 2011
The second-generation active Aβ immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effectsChristoph Wiessner, Karl-Heinz Wiederhold, Alain C Tissot, et al.
The Journal of Allergy and Clinical Immunology|May 7, 2019
Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjectsFranziska Thoms, Gary T Jennings, Melanie Maudrich, et al.
Immunity|April 23, 2005
CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cellsBenjamin J Marsland, Patrick Bättig, Monika Bauer, et al.
Plos One|August 11, 2017
Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particlesMarika Doucet, Aadil El-Turabi, Franziska Zabel, et al.
Pageof 52